Home/Sam Martin

About Sam Martin

This author has not yet filled in any details.
So far Sam Martin has created 10 blog entries.

Oral Antipsychotic Versus Long-acting Injections Antipsychotic In Schizophrenia Spectrum Disorder: A Mirror Analysis In A Real-world Clinical Setting

By |2019-05-29T14:08:15-08:00May 29th, 2019|Articles In Press|

Nicola Poloni, MD, PhD, Marta Ielmini, MD, PhD Student, Ivano Caselli, MD, PhD Student, Giulia Lucca, MD, Alessandra Gasparini, MD, Giorgia Lorenzoli, MD, Camilla Callegari, MD, PhD ABSTRACT Despite mixed results found in literature, long-acting injectable antipsychotics (LAIs) should offer better efficacy and tolerability, compared to oral antipsychotics due to improved [...]

Successful Resolution Of Prominent Somatic Delusions Following Bi-temporal Electroconvulsive Therapy In A Patient With Treatment- Resistant Schizoaffective Disorder

By |2019-05-24T16:20:42-08:00May 24th, 2019|Articles In Press|

Joshua L. Cohen, PhD, My-Hanh Thi Vu, MD, Mirza Adam Beg, BS, Soumya Sivaraman, MD, Badari Birur, MD ABSTRACT Somatic delusions occur in a variety of psychiatric disorders including schizophrenia, major depressive disorder, and bipolar disorder. Somatization is associated with lower quality of life and greater risk for suicide. Treatment [...]

Involuntary Facial Twitching In A Patient With Schizophrenia On Treatment With Long Acting Injectable Olanzapine

By |2019-05-24T16:18:53-08:00May 24th, 2019|Articles In Press|

Feras Ali Mustafa, Agastya Nayar ABSTRACT We report a case of a 49 year old Caucasian male with chronic schizophrenia and a history of non-compliance with treatment, due to lack of insight, resulting in multiple acute psychotic relapses that required compulsory admissions to hospital during which he was treated orally [...]

Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder

By |2019-05-24T16:14:28-08:00May 24th, 2019|Articles In Press|

Mark Mintz, MD and Emma Hollenberg ABSTRACT Objectives To examine the efficacy of lithium as a mood stabilizer for patients with autism spectrum disorder (ASD). Experimental Design A retrospective chart review was performed that examined the use of both extended and immediate release lithium carbonate in patients with ASD that [...]

Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks

By |2019-05-24T16:11:57-08:00May 24th, 2019|Articles In Press|

Johan Y. Cohen, Ariane Dumoulin-Charette, Nafaa Meraabi, and Raphaël Poirier ABSTRACT Schizophrenia, a disabling yet relatively common mental illness, is often controlled by antipsychotic drugs. However, long-term treatments are subject to non-adherence and consequent treatment failure. Non-adherence can be reduced by administration of slow-release drugs such as intramuscularly injected (IM) [...]

Delayed-Onset Toxicity In An Adolescent Case Following Attempted Suicide With An Overdose Of Paliperidone Intake

By |2019-04-01T18:18:30-08:00April 1st, 2019|Articles In Press|

Ferhat Yaylacı, Önder Küçük, and Handan Özek Erkuran ABSTRACT Paliperidone is a relatively novel atypical antipsychotic drug that is currently used to treat schizophrenia in adolescents and adults.  The drug was generated by combining the active metabolite of risperidone, 9- hydroxyrisperidone, with osmotic controlled- release oral administration system (OROS) technology. [...]

Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit

By |2019-04-01T18:16:49-08:00April 1st, 2019|Articles In Press|

Jenna L. Gilbert, Leigh Anne Nelson, Pharm.D., BCPP, Carrie R. Kriz, MS, Yifei Liu, B.S. Pharm, Ph.D., Courtney A. Iuppa, Pharm.D., BCPP, Lauren A. Diefenderfer, Pharm.D., BCPP, Ellie S.R. Elliott, Pharm.D., BCPP, and Roger W. Sommi, Pharm.D., BCPP, FCCP Abstract Describe primary adherence and medication persistence to second generation long-acting injectable (LAI) antipsychotics following an inpatient psychiatry [...]

Improved efficacy of pregabalin by restoring plasma vitamin D levels in migraine: a case report.

By |2019-02-15T12:23:46-08:00February 15th, 2019|Articles In Press|

Antonio Siniscalchi, MD; Piergiorgio Lochner; Erika Cione, PhD; Adelia Michniewicz, Biotechnologist; Vincenzo Guidetti, MD; Luca Gallelli, MD Abstract Migraine appears to be the most common neurological syndrome in primary care. Pain in migraine is mediated by the release of inflammatory mediators at the level of nerves and blood vessels. The antioxidant and neuroprotective effects of [...]

Successful Resolution of Prominent Somatic Delusions following Bi-temporal Electroconvulsive Therapy in a patient with Treatment- Resistant Schizoaffective disorder

By |2019-02-15T12:07:40-08:00February 15th, 2019|Articles In Press|

Joshua L. Cohen, PhD; My-Hanh Thi Vu, MD; Mirza Adam Beg, BS; Soumya Sivaraman, MD; and Badari Birur, MD Abstract Somatic delusions occur in a variety of psychiatric disorders including schizophrenia, major depressive disorder, and bipolar disorder. Somatization is associated with lower quality of life and greater risk for suicide. Treatment [...]

Psychopharmacology Bulletin Featured in EBSCO’s Latest Edition of New & Notable

By |2018-03-23T15:32:55-08:00March 23rd, 2018|MedWorks, We Know Psychiatry|

We are excited to announce that MedWorks Media's flagship journal, Psychopharmacology Bulletin, has been featured in EBSCO's latest issue of New & Notable. MedWorks Media (Psychopharmacology Bulletin) has partnered with EBSCO Information Services for over 15 years. EBSCO Information Services provides a complete and optimized research solution comprised [...]